UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000047070 |
|---|---|
| Receipt number | R000053696 |
| Scientific Title | Anti-aging skin care by nicotinamide mononucleotide metabolized from Vitamin B3 |
| Date of disclosure of the study information | 2022/04/01 |
| Last modified on | 2025/03/06 13:17:15 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Anti-aging skin care by nicotinamide mononucleotide metabolized from Vitamin B3
Acronym
Anti-aging skin care by nicotinamide mononucleotide
Scientific Title
Anti-aging skin care by nicotinamide mononucleotide metabolized from Vitamin B3
Scientific Title:Acronym
Anti-aging skin care by nicotinamide mononucleotide
Region
| Japan |
Condition
Condition
healthy skin
Classification by specialty
| Dermatology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To observe anti-aging effects
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Improvement of skin conditions
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
5
Purpose of intervention
Prevention
Type of intervention
| Other |
Interventions/Control_1
External application of No.1 cosmetics on the right half of the face at bedtime once a day for 8 weeks
Interventions/Control_2
External application of No.2 cosmetics on the right half of the face at bedtime once a day for 8 weeks
Interventions/Control_3
External application of No.3 cosmetics on the right half of the face at bedtime once a day for 8 weeks
Interventions/Control_4
External application of No.4 cosmetics on the right half of the face at bedtime once a day for 8 weeks
Interventions/Control_5
Oral administration of supplements after eating once a day for 8 weeks
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 45 | years-old | <= |
Age-upper limit
| 65 | years-old | >= |
Gender
Female
Key inclusion criteria
person with healthy skin conditions
Key exclusion criteria
person with eruptions on the face
Target sample size
25
Research contact person
Name of lead principal investigator
| 1st name | Yoshiaki |
| Middle name | |
| Last name | Kubo |
Organization
Tokushima university hospital
Division name
Dermatology
Zip code
770-8503
Address
50-2, Kuramoto-cho, Tokushima-city
TEL
088-633-7154
kubo@tokushima-u.ac.jp
Public contact
Name of contact person
| 1st name | Yoshiaki |
| Middle name | |
| Last name | Kubo |
Organization
Tokushima university hospital
Division name
Dermatology
Zip code
770-8503
Address
50-2, Kuramoto-cho, Tokushima-city
TEL
088-633-7154
Homepage URL
kubo@tokushima-u.ac.jp
Sponsor or person
Institute
Dermatology, Tokushima university hospital
Institute
Department
Personal name
Funding Source
Organization
None
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Dermatology, Tokushima university hospital
Address
50-2, Kuramoto-cho, Tokushima-city
Tel
088-633-7154
kubo@tokushima-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
徳島大学病院（徳島県）
Other administrative information
Date of disclosure of the study information
| 2022 | Year | 04 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2022 | Year | 02 | Month | 04 | Day |
Date of IRB
| 2022 | Year | 03 | Month | 29 | Day |
Anticipated trial start date
| 2022 | Year | 04 | Month | 01 | Day |
Last follow-up date
| 2028 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2022 | Year | 03 | Month | 04 | Day |
Last modified on
| 2025 | Year | 03 | Month | 06 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053696
